CODX vs LVS · rev $3.9M vs P/E 28, rev $2.90B
Co-Diagnostics, Inc. Common Stock (CODX) versus Las Vegas Sands Corp (LVS) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Las Vegas Sands Corp (LVS) is a resorts & casinos company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported LVS revenue for 2024-12-31 was $2.90B. Net income was $392.0M. Revenue was up 8.0% from 2024-09-30 to 2024-12-31. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
CODX currently screens at market cap $31.4M. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
Not investment advice. Open the CODX and LVS stock pages for the full models.
Not investment advice.